RSS-Feed abonnieren
DOI: 10.1055/s-0033-1357660
Das Reizdarmsyndrom − Integrative Therapie
Publikationsverlauf
Publikationsdatum:
26. Juni 2014 (online)
Zusammenfassung
Das Reizdarmsyndrom zählt zu den funktionellen Magen-Darm-Erkrankungen. Als typische Symptome treten Stuhlunregelmäßigkeiten, Obstipation, Diarrhö, Meteorismus und Schmerzen auf, die Lebensqualität der Patienten ist häufig sehr eingeschränkt. Die Genese der Erkrankung ist multifaktoriell, eine kausale und damit kurative Therapie besteht bis heute nicht. Der Autor gibt auf Basis der Leitlinienempfehlungen eine Übersicht zu den Möglichkeiten der integrativen Behandlung.
Abstract
The irritable bowel syndrome belongs to the functional gastrointestinal diseases. Typical symptoms are stool irregularities, obstipation, diarrhea, meteorism, and pain; often the quality of life of the patients is very restricted. The cause of the disease is multifactorial, and to this day, a causal and therefore curative therapy does not exist. Based on the guideline recommendations, the author presents an overview of the options of the integrative treatment.
-
Literatur
- 1 Eisenberg DM, Davis RB, Ettner SL et al. Alternative medicine consultationsn and remedies in patients with irritable bowel syndrome. GUT 1986; 27: 826-828
- 2 Kaptchuk TJ, Kelley JM, Conboy LA et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336 (7651): 999-1003
- 3 Csef H, Kraus MR Hrsg Psychosomatik in der Gastroenterologie. München, Jena: Urban und Fischer; 2000.
- 4 Drossmann DA et al. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120-2137
- 5 Layer P et al. Reizdarmsyndrom. Konsensus der DGVS. Z Gastroenterol 2011; 49: 237-293
- 6 Kruis W. Irritables Colon. In: Classen M, et al Innere Medizin. München, Wien, Baltimore: Urban und Schwarzenberg; 1994.
- 7 Gaylord SA, Palsson OS, Garland EL et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 2011; 106 (9): 1678-1688
- 8 Kanazawa M, Fukudo S. Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med 2006; 13 (3): 214-220
- 9 Forbes A, Jackson S, Walter C et al. Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial. World J Gastroenterol 2005; 11 (26): 4040-4044
- 10 Schneider A, Enck P, Streitberger K et al. Acupuncture treatment in irritable bowel syndrome. Gut 2006; 55 (5): 649-654
- 11 Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and meta-analysis. Am J Gastroenterol 1998; 93: 1131-1135
- 12 Madisch A, Holtmann G. Mayr et al. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomised, placebo-controlled, multicenter trial. Aliment Pharmacol Ther 2004; 3: 271-279
- 13 Palsson OS, Turner MJ, Johnson DA et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002; 11: 2605-2614
- 14 Keefer L, Blanchard EB. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study. Behav Res Ther 2001; 7: 801-811
- 15 Keefer L, Blanchard EB. A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome. Behav Res Ther 2002; 5: 541-546
- 16 Boyce PM, Talley NJ, Balaam B et al. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003; 10: 2209-2218
- 17 Harris MS. Irritable bowel syndrome: a cost-effective approach for primary care physicians. Postgrad Med 1997; 101: 3-15
- 18 Jailwala J, Imperiale TF, Kroenke K. Pharmacological treatment of the irritable bowel syndrome: a systematic review of randomised, controlled trials. Ann Intern Med 2000; 133: 136-147
- 19 Moser G et al. Long-term success of GUT-directed hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013; 108 (4): 602-609